MID-VOLUME · SEX-BALANCED

paliperidone Side Effects

paliperidone (also sold as Invega) sits MID-VOLUME #222 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 32% of sex-coded reports are female (5,980 F / 12,927 M). Demographics and serious-outcome tables follow.

Data updated 2026-05-15

22,775
FAERS reports

FDA Adverse Event Reporting System extract for paliperidone. Stamp set WATCHLIST · DEATH-MARKED · HOSP-MID. How figures are compiled.

paliperidone reporting skew - 32% of sex-coded reports are female (5,980 F / 12,927 M). Volume band MID-VOLUME #222 of 524 by FAERS report count; caseload WATCHLIST.

Mid-book FAERS page for paliperidone (Invega) (22,775 reports). Signature SEX-BALANCED. Dominant age band on file: 18-44. Educational reference only.

Counts from the openFDA FAERS extract (2007–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.

INJURY leads 4,331 of 22,775 reports

INJURY
4,331
GYNAECOMASTIA
3,664
ABNORMAL WEIGHT GAIN
1,660
WEIGHT INCREASED
1,361
HYPERPROLACTINAEMIA
1,255
GALACTORRHOEA
1,051
SEDATION
735
DYSTONIA
695
DYSKINESIA
686
SUICIDE ATTEMPT
662
TREATMENT NONCOMPLIANCE
651
SCHIZOPHRENIA
645
EMOTIONAL DISORDER
589
EXTRAPYRAMIDAL DISORDER
587
SOMNOLENCE
575
TREMOR
514
OBESITY
511

Who reports · age peak 18-44 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 5,980 (31%)
Male 12,927 (68%)
Unknown 95

Age peak 18-44 (5,235 reports)

0-17 1,496 (16%)
18-44 5,235 (54%)
45-64 2,377 (25%)
65-74 382 (4%)
75+ 129 (1%)

FAERS filings rising toward 2025

2007 2025

Reactions in Death Reports

Death appears on 801 reports (3.5% - MARKED). Reactions below co-occur in those rows only.

Reaction Reports
COMPLETED SUICIDE 213
DEATH 153
TOXICITY TO VARIOUS AGENTS 107
SCHIZOPHRENIA 52
DYSTONIA 47
BLOOD GLUCOSE INCREASED 45
DYSKINESIA 45
SEDATION 45
SUICIDE ATTEMPT 45
CONDITION AGGRAVATED 44
METABOLIC DISORDER 43
ANOSOGNOSIA 42
BLOOD PROLACTIN ABNORMAL 42
DISTURBANCE IN SOCIAL BEHAVIOUR 42
SEXUAL DYSFUNCTION 42
PERSONALITY CHANGE 41
ADVERSE DRUG REACTION 34
OVERDOSE 32

Reactions in Hospitalization Reports

Hospitalization mid-share (4,563, 20.0%). Co-reported reactions:

Reaction Reports
HOSPITALISATION 492
SCHIZOPHRENIA 250
TREATMENT NONCOMPLIANCE 245
PSYCHOTIC DISORDER 236
WEIGHT INCREASED 210
NEUROLEPTIC MALIGNANT SYNDROME 196
EXTRAPYRAMIDAL DISORDER 191
TACHYCARDIA 187
SOMNOLENCE 184
DRUG INTERACTION 183
TREMOR 182
SUICIDE ATTEMPT 179
CONFUSIONAL STATE 176
OVERDOSE 163
AGGRESSION 161
ANXIETY 155
CONDITION AGGRAVATED 146
SUICIDAL IDEATION 145
How to read paliperidone FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)

FAERS holds 22,775 voluntary reports linked to paliperidone (Invega), 2007-2025. Death is listed on 801 (3.5%). Hospitalization appears on 4,563 (20.0%). Top co-reported indication: Product Used For Unknown Indication.

Mid-volume extract - treat DEATH-MARKED · HOSP-MID as signal-detection rates next to 32% of sex-coded reports are female (5,980 F / 12,927 M).

Read with paliperidone

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.